Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_1
1
33%
Ph not_applicable
2
67%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Other(1)

Detailed Status

Enrolling by invitation2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 1

Trials by Phase

Phase 11 (33.3%)
N/A2 (66.7%)

Trials by Status

unknown133%
enrolling_by_invitation267%

Recent Activity

0 active trials
Showing 3 of 3
enrolling_by_invitationnot_applicable

Research Study for Patients With Neurological Diseases Which Evaluates the Patient Experience of the MemorEM Device

NCT07222605
enrolling_by_invitationnot_applicable

Pilot Trial Evaluating Patient Experience With the MemorEM for Patients With Neurological Diseases

NCT07049341
unknownphase_1

Transcranial Electromagnetic Treatment (TEMT) Against Alzheimer's Disease

NCT04271163

Clinical Trials (3)

Showing 3 of 3 trials
NCT07222605Not Applicable

Research Study for Patients With Neurological Diseases Which Evaluates the Patient Experience of the MemorEM Device

Enrolling By Invitation
NCT07049341Not Applicable

Pilot Trial Evaluating Patient Experience With the MemorEM for Patients With Neurological Diseases

Enrolling By Invitation
NCT04271163Phase 1

Transcranial Electromagnetic Treatment (TEMT) Against Alzheimer's Disease

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3